Evidence Review
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Jun 24, 2025; 16(6): 107016
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.107016
Comparison and trend analysis of cancer incidence in China and globally in 2022
Dan Hu, Jiang Yu, Jiao Feng, Ping Liu, Ji-Ming Chen, Hao-Ling Zhang
Dan Hu, Jiao Feng, Ji-Ming Chen, Department of Oral Ophthalmology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation base of Child Development and Critical Disorders, Chongqing Key Laboratory of Structural Birth Defect and Reconstruction, Chongqing 400014, China
Jiang Yu, Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
Ping Liu, Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China
Hao-Ling Zhang, Department of Biomedical Science, Advanced Medical and Dental Institute, University Sains Malaysia, Penang 13200, Malaysia
Hao-Ling Zhang, School of Public Health, Gansu University of Chinese Medicine, Lanzhou 730000, Gansu Province, China
Co-first authors: Dan Hu and Jiang Yu.
Co-corresponding authors: Ji-Ming Chen and Hao-Ling Zhang.
Author contributions: Hu D and Yu J conceived the concept, wrote the original draft and should be considered as co-first authors; Feng J and Liu P analyzed the data; Chen JM and Zhang HL contributed to the supervision of this manuscript, Chen JM provided strategic guidance during the design phases, ensuring the overall quality and direction of the research, Zhang HL similarly played a critical role in project management and data interpretation, offering valuable insights and assisting in the review and revision of the manuscript to ensure its academic rigor. The contributions of both authors were invaluable throughout the research process, and should be considered as co-corresponding authors; and all the authors have read and approved the final manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ji-Ming Chen, Professor, Department of Oral Ophthalmology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation base of Child Development and Critical Disorders, Chongqing Key Laboratory of Structural Birth Defect and Reconstruction, No. 136 Zhongshan 2nd Road, Yuzhong District, Chongqing 400014, China. cqjimi0567@163.com
Received: March 13, 2025
Revised: April 8, 2025
Accepted: April 29, 2025
Published online: June 24, 2025
Processing time: 99 Days and 11.5 Hours
Core Tip

Core Tip: This study compares the 2022 cancer incidence data from China and globally, analyzing trends in gender, geographic distribution, and economic factors. It highlights significant disparities in cancer burden between China and the world, examining high-incidence cancer types and associated risk factors. The findings emphasize the need for targeted prevention and control strategies, offering valuable insights for enhancing cancer management in China.